New York, January 31, 2013 — MTS Health Investors, LLC (“MTS”), the New-York based healthcare private equity firm, has announced the final close of its third fund. With this close, MTS collectively manages assets of over $330 million. MTS Health Investors III, LP (“MTS III”) represents MTS’s largest fund and will continue to focus on middle market investments in healthcare.
“We are pleased with the outcome of our fundraising process and believe that our increased fund size will put us on strong footing to continue to pursue our targeted investment strategy,” said Oliver T. Moses, Senior Managing Director at MTS.
Curtis Lane, also Senior Managing Director at MTS, added, “We feel fortunate to have many returning investors from prior funds and are pleased to have brought in an impressive cadre of new investors who we look forward to working with in the months and years ahead.”
MTS Health Investors, LLC, located in New York, is a healthcare private equity firm that makes investments in operating companies within the healthcare industry. MTS targets companies that provide cost-effective solutions in the services and low-technology manufacturing sectors of the healthcare industry. Industry sectors in which MTS invests include: providers of outsourced solutions to the healthcare industry; providers of direct medical services to patients in an institutional, ambulatory, or home setting; providers of managed care and other healthcare insurance services; distributors of medical products; and manufacturers of medical devices and supplies. For further information, please visit www.mtshealthinvestors.com